02696.HK
Shanghai Henlius Biotech, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 70.10
+1.52%Leverage
- Debt / equity
- 0.87x
- Net debt / equity
- 0.69x
- Debt / assets
- 0.30x
- Debt / EBITDA
- 3.23x
- Net debt / EBITDA
- 2.56x
Liquidity & coverage
- Current ratio
- 0.78x
- Quick ratio
- 0.65x
- Cash ratio
- 0.20x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -HKD 1.2B
Cash & dividend
- FCF / debt
- 0.10x
- Cash flow / debt
- 0.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026